Solas Capital Management, LLC

13F Holdings History for FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

Symbol: FENC on Nasdaq
Investment type: Equity / Common Shares, no par value
Latest Disclosed Ownership: 2.25M shares
Security Ownership: 8.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Solas Capital Management, LLC ownership in FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC)

2025-02-14 - Solas Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.25M shares of FENNEC PHARMACEUTICALS INC. Common Shares, no par value (FENC). This represents 8.2% percent ownership of the company. In their previous filing dated 2024-11-14, Solas Capital Management, LLC had reported owning 1.92M shares, indicating an increase of 17% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Solas Capital Management, LLC	8.2%	+17.1%	$11.3M	2.25M	+327,383	+17%	$5.01	13G/A	12/31/2024	14 Feb 2025 13:00:09
Solas Capital Management, LLC	7%		$9.64M	1.92M			$5.01	13G/A	9/30/2024	14 Nov 2024 13:58:24

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	10.4%	-0.08%	$18.5M	2.23M	-18,017	-0.8%	$8.30	Q2 2025
3/31/2025	7.71%		$13.7M	2.25M			$6.09	Q1 2025
12/31/2024	9.45%	+1.37%	$14.2M	2.25M	+327,383	+17%	$6.32	Q4 2024
9/30/2024	6.75%	+2.05%	$9.62M	1.92M	+583,536	+43.5%	$5.00	Q3 2024
6/30/2024	4.48%	+0.9%	$8.19M	1.34M	+229,767	+20.7%	$6.11	Q2 2024
3/31/2024	7.94%	-1.85%	$12.3M	1.11M	-268,280	-19.5%	$11.12	Q1 2024
12/31/2023	9.6%	-2.78%	$15.5M	1.38M	-347,054	-20.1%	$11.22	Q4 2023
9/30/2023	9.07%	+1.54%	$13M	1.73M	+286,539	+19.9%	$7.51	Q3 2023
6/30/2023	8.45%	+0.91%	$12.7M	1.44M	+154,485	+12%	$8.83	Q2 2023
3/31/2023	5.71%	+0.14%	$10.7M	1.28M	+32,155	+2.57%	$8.32	Q1 2023
12/31/2022	7.21%	+0.7%	$12M	1.25M	+121,221	+10.7%	$9.60	Q4 2022
9/30/2022	5.59%	-0.21%	$9.16M	1.13M	-42,349	-3.61%	$8.10	Q3 2022
6/30/2022	3.91%	+0.09%	$6.55M	1.17M	+27,720	+2.42%	$5.58^*	Q2 2022
3/31/2022	3.89%	+0.94%	$6.42M	1.15M	+277,939	+32%	$5.60	Q1 2022
12/31/2021	2.72%		$3.82M	868K			$4.40	Q4 2021
9/30/2021	5.69%		$8.18M	868K			$9.42	Q3 2021
6/30/2021	4.44%	+0.42%	$6.33M	868K	+67,857	+8.48%	$7.29	Q2 2021
3/31/2021	4.18%		$4.97M	800K			$6.21	Q1 2021
12/31/2020	4.55%		$5.96M	800K			$7.45	Q4 2020
9/30/2020	4.64%	-0.93%	$4.85M	800K	-160,000	-16.7%	$6.06	Q3 2020
6/30/2020	7.4%		$8.02M	960K			$8.35	Q2 2020
3/31/2020	6.17%	-0.08%	$5.7M	960K	-11,795	-1.21%	$5.94	Q1 2020
12/31/2019	6.06%	+0.18%	$6.31M	972K	+28,595	+3.03%	$6.49	Q4 2019
9/30/2019	4.69%	+0.46%	$4.54M	943K	+93,221	+11%	$4.81	Q3 2019
6/30/2019	3.47%	+3.47%	$3.4M	850K	+849,979	NEW	$4.00	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.